Clinical Trials Directory

Trials / Completed

CompletedNCT05931237

Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults

Evaluation of the Inter-individual Variability Associated With the Interaction Between Flavan-3-ols From Cranberry and Gut Microbiota - an Exploratory Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Laval University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Consumption of (poly)phenols is recognized to have beneficial effects on health. However, heterogeneous results are obtained in clinical trials due to high inter-individual variability. The objective of this pilot study is to characterize the inter-individual variability associated with the interaction of (poly)phenols from cranberry and gut microbiota. The participants (n=39) of this study are healthy adults aged between 23 and 63 years old and consumed cranberry extract rich in (poly)phenols for 4 days. Plasma, urine and feces were collected to quantify gut microbial (poly)phenols metabolites and to profile the fecal microbiota.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCranberry extract capsulesCranberry extract capsules (Prebiocran(TM))

Timeline

Start date
2021-09-09
Primary completion
2021-11-19
Completion
2021-11-19
First posted
2023-07-05
Last updated
2023-07-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05931237. Inclusion in this directory is not an endorsement.